Atlas Trials

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

Clinical trial NCT03383146 · TERMINATED

Trial details

NCT number
NCT03383146
Sponsor
Allergan
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
GastroparesisDiabetes Mellitus
Start date
2018-02-01
Primary completion
2020-11-05
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.